Read original article here


Appili Therapeutics Inc.’s common shares will begin trading on the main board of the Toronto Stock Exchange on Wednesday, after spending 15 months on the TSX Venture exchange.

The Halifax-based company, which is working on bringing a portfolio of anti-infectious drugs to market, issued a statement Monday saying the change would take place at the start of trading Wednesday. By trading on the main TSX board, the company will have exposure to a broader group of investors, which should make it easier to raise capital.